Article Versions Notes

Cazzaniga ME, Pronzato P, Amoroso D, Bernardo A, Biganzoli L, Bisagni G, Blasi L, Bria E, Cognetti F, Crinò L, et al. Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study. Cancers. 2024; 16(1):117. https://doi.org/10.3390/cancers16010117

Cazzaniga, Marina Elena, Paolo Pronzato, Domenico Amoroso, Antonio Bernardo, Laura Biganzoli, Giancarlo Bisagni, Livio Blasi, Emilio Bria, Francesco Cognetti, Lucio Crinò, and et al. 2024. "Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study" Cancers 16, no. 1: 117. https://doi.org/10.3390/cancers16010117

Cazzaniga, M. E., Pronzato, P., Amoroso, D., Bernardo, A., Biganzoli, L., Bisagni, G., Blasi, L., Bria, E., Cognetti, F., Crinò, L., De Laurentiis, M., Del Mastro, L., De Placido, S., Beano, A., Ferraù, F., Foladore, S., Forcignanò, R., Gamucci, T., Garrone, O., ... Mustacchi, G. (2024). Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study. Cancers, 16(1), 117. https://doi.org/10.3390/cancers16010117